Financial Consulate’s Indivior Pharmaceuticals INDV Stock Holding History

Financial Consulate’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$359	Buy	+10	New	+$378	﹤0.01%	1540

Other funds holding INDV

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Financial Consulate's INDV Position: Q3 2026 in Review

Financial Consulate opened a new position in Indivior Pharmaceuticals (INDV) in Q3 2026: 10 shares worth $359. The stake represents ﹤0.01% of the portfolio and ranks #1540 among its holdings.

45 funds tracked by Wall St. Rank hold INDV as of Q3 2026.

Financial Consulate held 10 shares of Indivior Pharmaceuticals worth $359 as of Q3 2026.
Indivior Pharmaceuticals was a new Financial Consulate position in Q3 2026.
Indivior Pharmaceuticals made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1540 holding.
45 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.